Orca Bio’s Orca-Q receives US FDA’s RMAT designation for treatment of high-risk hematologic malignancies: Menlo Park, California Orca ...

Lilly supports Haryana State-FDA action on counterfeits, reiterates sourcing via authorised channels on valid prescription: ...

Pfizer announces positive results from phase 3 MagnetisMM-5 study of Elrexfio as monotherapy in adults with relapsed or refractory multiple myeloma: New York Thursday, April 30, 2 ...

US FDA grants priority review to BeOne Medicines’ sBLA for Tevimbra in first-line HER2+ GEA: San Carlos, California Thursday, April 30, 2026, 16:00 Hrs [IST] BeOne Medicines Ltd ...

New study highlights societal optimism toward breakthrough science, and rising anxiety about how fast the world is changing: Berlin Thursday, April 30, 202 ...

Pfizer Inc. announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, regarding lawsuits filed in the US District ...

Syngene PAT before exceptional items slips in Q3 by 16%, revenue up 2% to Rs. 1,037 crore: Our Bureau, Bengaluru Thursday, April 30, 2026, 13:30 Hrs [IST] Syngene International, I ...

China’s CDE accepts marketing authorization application for Bayer’s asundexian to prevent ischemic stroke in patients after a non-cardioembolic ischemic stroke or TIA: Berlin ...

Samsung Bioepis & ATLATL ink MoU to accelerate early-stage biotech innovation in Asia-Pacific: Incheon, Korea Thursday, April 30, 2026, 11:00 Hrs [IST] Samsung Bioepis Co., Ltd. a ...

Abbott receives US FDA clearance and CE Mark for next-generation Ultreon 3.0 AI-powered coronary imaging platform: Abbott Park, Illinois Thursday, April 30, 2026, 14:00 Hrs [IST] ...

Parexel adds new technology capabilities in patient safety solutions with acquisition of Vitrana: Our Bureau, Bengaluru Thursday, April 30, 2026, 13:45 Hrs [IST] Parexel, a leadin ...

NHPC organises Heart Health Talk and Awareness Camp in association with Heartnet India: Our Bureau, Mumbai Thursday, April 30 ...